About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 965853, 7 pages
http://dx.doi.org/10.1155/2013/965853
Clinical Study

Increased Production of Interleukin-4, Interleukin-10, and Granulocyte-Macrophage Colony-Stimulating Factor by Type 2 Diabetes’ Mononuclear Cells Infected with Dengue Virus, but Not Increased Intracellular Viral Multiplication

1Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
2Chang Gung University Medical College, Tao-Yuan 333, Taiwan
3Infection Control Committee, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
4Division of Endocrinology & Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
5Department of Medical Research, Show Chwan Memorial Hospital, Changhua 500, Taiwan
6Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
7Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
8Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
9Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan

Received 9 May 2013; Revised 3 July 2013; Accepted 5 July 2013

Academic Editor: Patrizia Bagnarelli

Copyright © 2013 Ing-Kit Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 2009.
  2. C. P. Simmons, J. J. Farrar, N. van Vinh Chau, and B. Wills, “Current concepts: Dengue,” The New England Journal of Medicine, vol. 366, no. 15, pp. 1423–1432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Halstead, “Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion,” Yale Journal of Biology and Medicine, vol. 42, no. 5, pp. 350–362, 1970. View at Scopus
  4. D. M. Morens, “Antibody-dependent enhancement of infection and the pathogenesis of viral disease,” Clinical Infectious Diseases, vol. 19, no. 3, pp. 500–512, 1994. View at Scopus
  5. R. Rico-Hesse, L. M. Harrison, A. Nisalak et al., “Molecular evolution of dengue type 2 virus in Thailand,” American Journal of Tropical Medicine and Hygiene, vol. 58, no. 1, pp. 96–101, 1998. View at Scopus
  6. B. D. Pandey and A. Igarashi, “Severity-related molecular differences among nineteen strains of dengue type 2 viruses,” Microbiology and Immunology, vol. 44, no. 3, pp. 179–188, 2000. View at Scopus
  7. N. T. Lan and K. Hirayama, “Host genetic susceptibility to severe dengue infection,” Tropical Medicine and International Health, vol. 39, supplement 4, pp. 73–81, 2011.
  8. I.-K. Lee, J.-W. Liu, and K. D. Yang, “Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever,” American Journal of Tropical Medicine and Hygiene, vol. 79, no. 2, pp. 149–153, 2008. View at Scopus
  9. M. G. Guzmán, G. Kouri, J. Bravo, L. Valdes, V. Susana, and S. B. Halstead, “Effect of age on outcome of secondary dengue 2 infections,” International Journal of Infectious Diseases, vol. 6, no. 2, pp. 118–124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Pang, A. Salim, V. J. Lee, et al., “Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study,” PLoS Neglected Tropical Diseases, vol. 6, no. 5, article e1641, 2012.
  11. M. A. Figueiredo, L. C. Rodrigues, M. L. Barreto et al., “Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study,” PLoS Neglected Tropical Diseases, vol. 4, no. 6, article e699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Limonta, G. Torres, V. Capó, and M. G. Guzmán, “Apoptosis, vascular leakage and increased risk of severe dengue in a type 2 diabetes mellitus patient,” Diabetes and Vascular Disease Research, vol. 5, no. 3, pp. 213–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Bravo, M. G. Guzmán, and G. P. Kouri, “Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS),” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 81, no. 5, pp. 816–820, 1987. View at Scopus
  14. I. Conget, “Diagnosis, classification and pathogenesis of diabetes mellitus,” Revista Española de Cardiologia, vol. 55, no. 5, pp. 528–535, 2002. View at Scopus
  15. T. Benfield, J. S. Jensen, and B. G. Nordestgaard, “Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome,” Diabetologia, vol. 50, no. 3, pp. 549–554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Stolar, “Glycemic control and complications in type 2 diabetes mellitus,” American Journal of Medicine, vol. 123, no. 3, pp. S3–S11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. U. C. Chaturvedi, R. Agarwal, E. A. Elbishbishi, and A. S. Mustafa, “Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis,” FEMS Immunology and Medical Microbiology, vol. 28, no. 3, pp. 183–188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Nakayamada, H. Takahashi, Y. Kanno, and J. J. O'Shea, “Helper T cell diversity and plasticity,” Current Opinion in Immunology, vol. 24, no. 3, pp. 297–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. T. R. Mosmann and S. Sad, “The expanding universe of T-cell subsets: Th1, Th2 and more,” Immunology Today, vol. 17, no. 3, pp. 138–146, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. U. C. Chaturvedi, E. A. Elbishbishi, R. Agarwal, et al., “Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures,” Journal of Medical Virology, vol. 59, no. 3, pp. 335–340, 1999.
  21. R.-F. Chen, J.-W. Liu, W.-T. Yeh et al., “Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever,” FEMS Immunology and Medical Microbiology, vol. 44, no. 1, pp. 43–50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. R.-F. Chen, K. D. Yang, L. Wang, J.-W. Liu, C.-C. Chiu, and J.-T. Cheng, “Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 101, no. 11, pp. 1106–1113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Green, D. W. Vaughn, S. Kalayanarooj, et al., “Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity,” Journal of Medical Virology, vol. 59, no. 3, pp. 329–334, 1999.
  24. W.-T. Yeh, R.-F. Chen, L. Wang, J.-W. Liu, M.-F. Shaio, and K. D. Yang, “Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever,” FEMS Immunology and Medical Microbiology, vol. 48, no. 1, pp. 84–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Groen, P. Koraka, J. Velzing, C. Copra, and A. D. M. E. Osterhaus, “Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies,” Clinical and Diagnostic Laboratory Immunology, vol. 7, no. 6, pp. 867–871, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. R.-F. Chen, W.-T. Yeh, M.-Y. Yang, and K. D. Yang, “A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections,” FEMS Immunology and Medical Microbiology, vol. 30, no. 1, pp. 1–7, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. K. D. Yang, C.-L. Wang, and M.-F. Shaio, “Production of cytokines and platelet activating factor in secondary dengue virus infections,” Journal of Infectious Diseases, vol. 172, no. 2, pp. 604–605, 1995. View at Scopus
  28. D. R. Palmer, P. Sun, C. Celluzzi et al., “Differential effects of dengue virus on infected and bystander dendritic cells,” Journal of Virology, vol. 79, no. 4, pp. 2432–2439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T.-H. Chang, S.-R. Chen, C.-Y. Yu, et al., “Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-κB activation to downregulate cytokine production,” PLoS One, vol. 7, no. 8, article e41635, 2012.
  30. D. H. Libraty, S. Pichyangkul, C. Ajariyakhajorn, T. P. Endy, and F. A. Ennis, “Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis,” Journal of Virology, vol. 75, no. 8, pp. 3501–3508, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Kurane, “Dengue hemorrhagic fever with special emphasis on immunopathogenesis,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 30, no. 5-6, pp. 329–340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. Y.-R. Lee, M.-T. Liu, H.-Y. Lei et al., “MCP1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells,” Journal of General Virology, vol. 87, no. 12, pp. 3623–3630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Bernasconi, C. Matteucci, M. Sironi et al., “Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages,” International Journal of Cancer, vol. 60, no. 3, pp. 300–307, 1995. View at Scopus
  34. K. G. Oliver, J. R. Kettman, and R. J. Fulton, “Multiplexed analysis of human cytokines by use of the flowmetrix system,” Clinical Chemistry, vol. 44, no. 9, pp. 2057–2060, 1998. View at Scopus
  35. C.-Y. Tsai, I.-K. Lee, C.-H. Lee, K. D. Yang, and J.-W. Liu, “Comparisons of dengue illness classified based on the 1997 and 2009 World Health Organization dengue classification schemes,” Journal of Microbiology, Immunology and Infection, vol. 46, no. 4, pp. 271–281, 2013. View at Publisher · View at Google Scholar
  36. B. Spellberg and J. E. Edwards Jr., “Type 1/type 2 immunity in infectious diseases,” Clinical Infectious Diseases, vol. 32, no. 1, pp. 76–102, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. D. H. Libraty, T. P. Endy, H.-S. H. Houng et al., “Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections,” Journal of Infectious Diseases, vol. 185, no. 9, pp. 1213–1221, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. W.-K. Wang, D.-Y. Chao, C.-L. Kao et al., “High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis,” Virology, vol. 305, no. 2, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Tilg and A. R. Moschen, “Inflammatory mechanisms in the regulation of insulin resistance,” Molecular Medicine, vol. 14, no. 3-4, pp. 222–231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Bernasconi, C. Matteucci, M. Sironi et al., “Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages,” International Journal of Cancer, vol. 60, no. 3, pp. 300–307, 1995. View at Scopus
  41. F. A. Bozza, O. G. Cruz, S. M. Zagne et al., “Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity,” BMC Infectious Diseases, vol. 8, article 86, 2008. View at Publisher · View at Google Scholar · View at Scopus